control nonimmune serum (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
99
Structured Review
Agilent technologies
control nonimmune serum
Control Nonimmune Serum, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 99/100, based on 25300 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+nonimmune+serum/Streptavidin/pm17680316-26-36-62
Average 99 stars, based on 25300 article reviews
Control Nonimmune Serum, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 99/100, based on 25300 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+nonimmune+serum/Streptavidin/pm17680316-26-36-62
Average 99 stars, based on 25300 article reviews
control nonimmune serum - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Blocking Assay:Article Title: Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Article Snippet: Department of Pathology and Laboratory Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, 95 Wen-Chang Road, Taipei, Taiwan Department of Pathology, Taipei Medical University, 250 Wu-Xin Street, Taipei, Taiwan Department of Pathology, National Taiwan University Hospital and College of Medicine, National Taiwan University, 7 Chung-Shan South Road, Taipei, Taiwan National Center of Excellence for General Clinical Trial and Research, National Taiwan University Hospital and Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, 17 Xu-Chou Road, Taipei, Taiwan Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University, 7 Chung-Shan South Road, Taipei, Taiwan Department of Surgery, Tao-Yuan General Hospital, Department of Health, Executive Yuan, R.O.C, 1492 Chung-Shan Road, Tao-Yuan City, Taiwan Control:Article Title: Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Article Snippet: Department of Pathology and Laboratory Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, 95 Wen-Chang Road, Taipei, Taiwan Department of Pathology, Taipei Medical University, 250 Wu-Xin Street, Taipei, Taiwan Department of Pathology, National Taiwan University Hospital and College of Medicine, National Taiwan University, 7 Chung-Shan South Road, Taipei, Taiwan National Center of Excellence for General Clinical Trial and Research, National Taiwan University Hospital and Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, 17 Xu-Chou Road, Taipei, Taiwan Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University, 7 Chung-Shan South Road, Taipei, Taiwan Department of Surgery, Tao-Yuan General Hospital, Department of Health, Executive Yuan, R.O.C, 1492 Chung-Shan Road, Tao-Yuan City, Taiwan Incubation:Article Title: Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Article Snippet: Department of Pathology and Laboratory Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, 95 Wen-Chang Road, Taipei, Taiwan Department of Pathology, Taipei Medical University, 250 Wu-Xin Street, Taipei, Taiwan Department of Pathology, National Taiwan University Hospital and College of Medicine, National Taiwan University, 7 Chung-Shan South Road, Taipei, Taiwan National Center of Excellence for General Clinical Trial and Research, National Taiwan University Hospital and Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, 17 Xu-Chou Road, Taipei, Taiwan Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University, 7 Chung-Shan South Road, Taipei, Taiwan Department of Surgery, Tao-Yuan General Hospital, Department of Health, Executive Yuan, R.O.C, 1492 Chung-Shan Road, Tao-Yuan City, Taiwan |